HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development.

HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development.
复制标题

OXA9 通过与 CRIP2 相互作用抑制 HIF-1α 介导的糖酵解,从而抑制皮肤鳞状细胞癌的发展。

DOI:
10.1038/s41467-018-03914-5
复制
发表时间:
2018-04-16
影响因子:
16.6
通讯作者:
Ding Z
Ding Z
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Zhou L;Wang Y;Zhou M;Zhang Y;Wang P;Li X;Yang J;Wang H;Ding Z

文献摘要

参考文献

被引文献

相似文献

糖酵解重编程是许多癌症的典型特征;然而,对葡萄糖代谢重组的关键调节因子知之甚少,特别是在皮肤鳞状细胞癌(cSCC)中。在此,同源框A9(HOXA 9),癌-miR-365的直接靶点,被鉴定为在cSCC肿瘤和细胞系中显著下调。HOXA 9作为肿瘤抑制因子,通过负调控HIF-1α及其下游糖酵解调节因子HK 2、GLUT 1和PDK 1,在体外和体内抑制cSCC中的糖酵解。机制研究表明,HOXA 9-CRIP 2在糖酵解基因启动子的相互作用阻碍了HIF-1α的结合,抑制了基因的反式表达。我们的研究结果揭示了miR-365-HOXA 9-HIF-1α调节轴,有助于增强cSCC发展中的糖酵解,并可能代表cSCC治疗的干预靶点。缺氧诱导转录因子HIF-1α促进糖酵解,使细胞在应激下存活。在这里,作者使用细胞系和动物模型表明,在皮肤鳞状细胞癌中,HOXA 9作为肿瘤抑制因子,通过与CRIP 2结合抑制HIF-1α与靶基因的结合来抑制糖酵解。
Glycolytic reprogramming is a typical feature of many cancers; however, key regulators of glucose metabolism reengineering are poorly understood, especially in cutaneous squamous cell carcinoma (cSCC). Here, Homeobox A9 (HOXA9), a direct target of onco-miR-365, is identified to be significantly downregulated in cSCC tumors and cell lines. HOXA9 acts as a tumor suppressor and inhibits glycolysis in cSCC in vitro and in vivo by negatively regulating HIF-1α and its downstream glycolytic regulators, HK2, GLUT1 and PDK1. Mechanistic studies show that HOXA9-CRIP2 interaction at glycolytic gene promoters impeds HIF-1α binding, repressing gene expression in trans. Our results reveal a miR-365-HOXA9-HIF-1α regulatory axis that contributes to the enhanced glycolysis in cSCC development and may represent an intervention target for cSCC therapy. Hypoxia-inducible transcription factor HIF-1α promotes glycolysis allowing cell survival under stress. Here the authors show, using both cell lines and animal models, that in cutaneous squamous cell carcinoma HOXA9 acts as a tumor suppressor and inhibits glycolysis by associating with CRIP2 to repress HIF-1α binding to target genes.
DOI: 10.1038/21224
发表时间: 1999-06-10
期刊: NATURE
影响因子: 64.8
作者:
Dimmeler, S;Fleming, I;Zeiher, AM
通讯作者: Zeiher, AM
DOI: 10.1007/s10059-009-0148-2
发表时间: 2009-12-01
影响因子: 3.8
作者:
Cho, Young-Suk;Kim, Chan-Hyung;Park, Jong-Wan
通讯作者: Park, Jong-Wan
DOI: 10.1182/blood-2007-09-113597
发表时间: 2009-03-12
期刊: BLOOD
影响因子: 20.3
作者:
Faber, Joerg;Krivtsov, Andrei V.;Armstrong, Scott A.
通讯作者: Armstrong, Scott A.
DOI: 10.1172/jci39534
发表时间: 2010-05-01
影响因子: 15.9
作者:
Gilbert, Penney M.;Mouw, Janna K.;Weaver, Valerie M.
通讯作者: Weaver, Valerie M.
DOI: 10.1111/j.1751-1097.2008.00482.x
发表时间: 2009-05-01
影响因子: 3.3
作者:
Guo, Ling;Huang, Zhong-Xi;Ding, Zhen-Hua
通讯作者: Ding, Zhen-Hua